Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study. [electronic resource]
Producer: 20150716Description: 2239-46 p. digitalISSN:- 1536-4844
- Adult
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Chemical and Drug Induced Liver Injury -- drug therapy
- Cohort Studies
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Hyperplasia -- drug therapy
- Inflammatory Bowel Diseases -- drug therapy
- Liver -- drug effects
- Male
- Middle Aged
- Prognosis
- Severity of Illness Index
- Thioguanine -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.